Oct 1 (Reuters) – An experimental biotech drug developed by
Johnson & Johnson proved more effective at clearing
moderate to severe cases of the skin condition plaque psoriasis
than a placebo or…
The post J&J psoriasis drug tops placebo, Humira in late stage study appeared first on NASDAQ.